Back to Search
Start Over
Effect of pexelizumab, an anti-C5 complement antibody, as adjunctive therapy to fibrinolysis in acute myocardial infarction: the COMPlement inhibition in myocardial infarction treated with thromboLYtics (COMPLY) trial.
- Source :
- Circulation; 2003 Sep 9, Vol. 108 Issue 10, p1176-1183, 8p
- Publication Year :
- 2003
Details
- Language :
- English
- ISSN :
- 00097322
- Volume :
- 108
- Issue :
- 10
- Database :
- Complementary Index
- Journal :
- Circulation
- Publication Type :
- Academic Journal
- Accession number :
- 106699832